Company GlaxoSmithKline Pakistan Limited

Equities

GLAXO

PK0001301016

Pharmaceuticals

End-of-day quote Pakistan S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
85.68 PKR +1.48% Intraday chart for GlaxoSmithKline Pakistan Limited +0.62% +3.24%

Business Summary

GlaxoSmithKline Pakistan Limited is a Pakistan-based global biopharma company. The Company is engaged in the manufacturing and marketing of research-based specialties and pharmaceutical products. It caters to therapy areas, such as anti-infectives, dermatology, respiratory, analgesics, urology and vaccines. Its pharmaceutical brands include Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol and Ventolin. Its portfolio has three product areas: vaccines, specialty and general medicines. Its Amoxil branded products are an antibiotic indicated for the treatment of upper respiratory tract infections and helicobacter pylori. Its Vates portfolio comprises brands, such as Dermovate, Clobevate, Cutivate and Betnovate. Its Vates portfolio addresses to a broad category of steroid responsive dermatoses indications, including but not limited to psoriasis, contact, and other kinds of dermatitis. Its Calpol branded products are used for treatment of mild to moderate fever and pain.

Number of employees: 1,768

Sales per Business

PKR in Million2021Weight2022Weight Delta
Pharmaceutical
100.0 %
36,661 100.0 % 41,842 100.0 % +14.13%

Sales per region

PKR in Million2021Weight2022Weight Delta
Pakistan
100.0 %
36,661 100.0 % 41,842 100.0 % +14.13%

Managers

Managers TitleAgeSince
Chief Executive Officer - 20-02-29
Director of Finance/CFO - 21-05-31
Compliance Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Chief Administrative Officer - -
Comptroller/Controller/Auditor - 22-05-22
Corporate Officer/Principal - -
Corporate Officer/Principal - -
General Counsel - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 20-04-01
Director/Board Member - 18-12-04
Chief Executive Officer - 20-02-29
Director/Board Member - 11-05-06
Director of Finance/CFO - 21-05-31
Director/Board Member - 22-09-27
Chairman - 22-08-04

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 318,467,278 45,032,162 ( 14.14 %) 0 14.14 %

Shareholders

NameEquities%Valuation
GSK PLC
82.59 %
263,029,794 82.59 % 81 M ₨
State Life Insurance Corp. of Pakistan
2.882 %
9,176,686 2.882 % 3 M ₨
National Investment Trust Ltd.
2.415 %
7,692,356 2.415 % 2 M ₨
Faysal Bank Ltd. (Investment Management)
0.2586 %
823,540 0.2586 % 255 042 ₨
Dawood Capital Management Ltd. (Investment Management)
0.1251 %
398,362 0.1251 % 123 369 ₨
AKD Investment Management Ltd.
0.005738 %
18,273 0.005738 % 5 659 ₨
NBP Fund Management Ltd.
0.001099 %
3,500 0.001099 % 1 084 ₨
First Capital Investments Ltd.
0.000942 %
3,000 0.000942 % 929 ₨
JS Investments Ltd. (Investment Management)
0.000671 %
2,137 0.000671 % 662 ₨

Company contact information

GlaxoSmithKline Pakistan Ltd.

35, Dockyard Road West Wharf

74000, Karachi

+

http://www.pk.gsk.com
address GlaxoSmithKline Pakistan Limited(GLAXO)